Journal of Neurotrauma,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
There
has
been
limited
exploration
of
blood-based
biomarkers
in
the
chronic
period
following
traumatic
brain
injury
(TBI).
Our
objective
was
to
conduct
a
systematic
review
studies
examining
protein
with
at
least
one
sample
collected
12
months
post-TBI
adults
(≥16
years).
Database
searches
were
conducted
Embase,
MEDLINE,
and
Science
Citation
Index-Expanded
on
July
24,
2023.
Risk
bias
assessed
using
modified
Joanna
Briggs
Institute
critical
appraisal
tools.
Only
30
12,523
articles
met
inclusion
criteria,
samples
drawn
from
48
years.
Higher
quality
evidence
(low
risk
bias;
large
samples)
identified
promising
inflammatory
post-injury
both
moderate-severe
TBI
(GFAP)
mild
(eotaxin-1,
IFN-y,
IL-8,
IL-9,
IL-17A,
MCP-1,
MIP-1β,
FGF-basic,
TNF-α).
Studies
low
but
smaller
also
suggest
NSE,
MME,
CRP
may
be
informative,
alongside
variants
for
α-syn
(10H,
D5),
amyloid-β
(A4,
C6T),
TDP-43
(AD-TDP
1;2;3;9;11),
tau
(D11C).
Findings
NfL
inconclusive.
Longitudinal
data
mostly
available
acute
followed
until
post-injury,
evaluation
changes
beyond
months.
Associations
some
cognitive,
sleep,
functional
outcomes
reported.
The
overall
strength
this
by
small
sizes.
Replication
is
required
within
prospective
longitudinal
that
move
post-injury.
Novel
efforts
should
guided
neurodegenerative-disease
markers
use
panels
model
polypathology.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(12), P. 9882 - 9882
Published: June 8, 2023
Skin
interstitial
fluid
(ISF)
has
emerged
as
a
fungible
biofluid
sample
for
blood
serum
and
plasma
disease
diagnosis
therapy.
The
sampling
of
skin
ISF
is
highly
desirable
considering
its
easy
accessibility,
no
damage
to
vessels,
reduced
risk
infection.
Particularly,
can
be
sampled
using
microneedle
(MN)-based
platforms
in
the
tissues,
which
exhibit
multiple
advantages
including
minimal
invasion
less
pain,
ease
carrying,
capacity
continuous
monitoring,
etc.
In
this
review,
we
focus
on
current
development
microneedle-integrated
transdermal
sensors
collecting
detecting
specific
biomarkers.
Firstly,
discussed
classified
microneedles
according
their
structural
design,
solid
MNs,
hollow
porous
coated
MNs.
Subsequently,
elaborate
construction
MN-integrated
metabolic
analysis
with
highlights
electrochemical,
fluorescent,
chemical
chromogenic,
immunodiagnostic,
molecular
diagnostic
sensors.
Finally,
discuss
challenges
future
direction
developing
MN-based
extraction
sensing
applications.
Intensive Care Medicine Experimental,
Journal Year:
2024,
Volume and Issue:
12(1)
Published: Jan. 5, 2024
Abstract
Acute
brain
injuries,
such
as
traumatic
injury
and
ischemic
hemorragic
stroke,
are
a
leading
cause
of
death
disability
worldwide.
While
characterized
by
clearly
distict
primary
events—vascular
damage
in
strokes
biomechanical
injuries—they
share
common
secondary
mechanisms
influencing
long-term
outcomes.
Growing
evidence
suggests
that
more
personalized
approach
to
optimize
energy
substrate
delivery
the
injured
prognosticate
towards
families
could
be
beneficial.
In
this
context,
continuous
invasive
and/or
non-invasive
neuromonitoring,
together
with
clinical
evaluation
neuroimaging
support
strategies
cerebral
blood
flow
metabolic
delivery,
well
approaches
neuroprognostication
gaining
interest.
Recently,
European
Society
Intensive
Care
Medicine
organized
2-day
course
focused
on
practical
case-based
acute
brain-injured
patients
different
scenarios
future
perspectives
advance
management
population.
The
aim
manuscript
is
update
clinicians
dealing
intensive
care
unit,
describing
current
knowledge
practice
based
insights
presented
during
course.
Trends in Neurosciences,
Journal Year:
2024,
Volume and Issue:
47(9), P. 677 - 692
Published: Aug. 10, 2024
Traumatic
brain
injury
(TBI)
is
a
complex
condition
that
can
resolve
over
time
but
all
too
often
leads
to
persistent
symptoms,
and
the
risk
of
poor
patient
outcomes
increases
with
aging.
TBI
damages
neurons
long
axons
within
white
matter
tracts
are
critical
for
communication
between
regions;
this
causes
slowed
information
processing
neuronal
circuit
dysfunction.
This
review
focuses
on
after
multifactorial
processes
underlie
damage,
potential
recovery,
progression
degeneration.
A
multiscale
perspective
across
clinical
preclinical
advances
presented
encourage
interdisciplinary
insights
from
whole-brain
neuroimaging
down
cellular
molecular
responses
axons,
myelin,
glial
cells
tissue.
Sports Medicine - Open,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Jan. 25, 2024
Amidst
growing
concern
about
the
safety
of
sport-related
repetitive
subconcussive
head
impacts
(RSHI),
biofluid
markers
may
provide
sensitive,
informative,
and
practical
assessment
effects
RSHI
exposure.
This
scoping
review
aimed
to
systematically
examine
extent,
nature,
quality
available
evidence
from
studies
investigating
on
markers,
identify
gaps
formulate
guidelines
inform
future
research.
PRISMA
extension
for
Scoping
Reviews
were
adhered
to.
The
protocol
was
pre-registered
through
publication.
MEDLINE,
Scopus,
SPORTDiscus,
CINAHL,
PsycINFO,
Cochrane
Library,
OpenGrey,
two
clinical
trial
registries
searched
(until
March
30,
2022)
using
descriptors
impacts,
biomarkers,
contact
sports.
Included
assessed
risk
bias
quality.
Seventy-nine
research
publications
included
in
review.
Forty-nine
acute
effects,
23
semi-acute
26
long-term
most
studied
sports
American
football,
boxing,
soccer,
investigated
(in
descending
order):
S100
calcium-binding
protein
beta
(S100B),
tau,
neurofilament
light
(NfL),
glial
fibrillary
acidic
(GFAP),
neuron-specific
enolase
(NSE),
brain-derived
neurotrophic
factor
(BDNF),
phosphorylated
tau
(p-tau),
ubiquitin
C-terminal
hydrolase
L1
(UCH-L1),
hormones.
High
or
moderate
found
studies,
marker-specific
conclusions
subject
heterogeneous
limited
evidence.
Although
is
weak,
some
markers-such
as
NfL-appeared
show
promise.
More
markedly,
S100B
be
problematic
when
evaluating
sport.
Considering
limitations
base
revealed
by
this
first
dedicated
marker
levels
following
exposure,
field
evidently
still
its
infancy.
As
a
result,
any
recommendation
application
premature.
promise
brain
health
large
standardized
better-controlled
are
needed
determine
markers'
utility.
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(6), P. 4159 - 4173
Published: May 15, 2024
We
evaluated
associations
between
plasma
and
neuroimaging-derived
biomarkers
of
Alzheimer's
disease
related
dementias
the
impact
health-related
comorbidities.
EClinicalMedicine,
Journal Year:
2024,
Volume and Issue:
75, P. 102751 - 102751
Published: Aug. 8, 2024
BackgroundEven
patients
with
normal
computed
tomography
(CT)
head
imaging
may
experience
persistent
symptoms
for
months
to
years
after
mild
traumatic
brain
injury
(mTBI).
There
is
currently
no
good
way
predict
recovery
and
triage
who
benefit
from
early
follow-up
targeted
intervention.
We
aimed
assess
if
existing
prognostic
models
can
be
improved
by
serum
biomarkers
or
diffusion
tensor
metrics
(DTI)
MRI,
identify
DTI.MethodsWe
included
1025
aged
>18
a
Glasgow
Coma
Score
>12
CT
the
Collaborative
European
NeuroTrauma
Effectiveness
Research
in
Traumatic
Brain
Injury
(CENTER-TBI)
study
which
recruited
between
December
19,2014
17,
2017
(NCT02210221).
Biomarkers
(GFAP,
NFL,
S100B)
were
obtained
at
median
of
8.8
h
(Q1–Q3
4.2–16.7)
DTI
13
days
(3–19)
injury.
available
153
48
white
matter
tracts
(ICBM-DTI-81
atlas).
Incomplete
three
was
defined
as
an
extended
Outcome
Scale
score
<8.
Existing
fitted
without
biomarkers,
DTI,
internally
validated
using
bootstrapping.Findings385
(38%)
had
incomplete
recovery.
Adding
did
not
improve
performance
beyond
best
clinical
model
[optimism-corrected
AUC
0.69
(95%
CI
0.65–0.72)
R2
17%
(11–22)].
significantly
enhanced
all
[best
optimism-corrected
0.82
(0.79–0.85)
75%
(39–100)].
The
top
left
posterior
thalamic
radiation,
superior
cerebellar
peduncle
right
uncinate
fasciculus.
Serum
could
have
avoided
1
5
scans,
GFAP
<12
NFL
12–24
performing
best.InterpretationDTI
substantially
functional
outcome
mTBI
CT,
help
select
MRI.
If
validated,
allow
enrichment
trials
interventions
outcome.FundingEU
Seventh
Framework
Programme,
Hannelore
Kohl
Stiftung,
One
Mind,
Integra
LifeSciences,
Sciences.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: Oct. 4, 2022
COVID-19
is
renowned
as
a
multi-organ
disease
having
subacute
and
long-term
effects
with
broad
spectrum
of
clinical
manifestations.
The
evolving
scientific
evidence
demonstrates
that
the
frequency
cognitive
impairment
after
high
it
crucial
to
explore
more
research
implement
proper
diagnostic
treatment
strategies.
Several
central
nervous
system
complications
have
been
reported
comorbidities
COVID-19.
changes
in
function
associated
neurodegenerative
diseases
develop
slowly
over
time
are
only
diagnosed
at
an
already
advanced
stage
molecular
pathology.
Hence,
understanding
common
links
between
will
broaden
our
knowledge
help
strategizing
prognostic
therapeutic
approaches.
present
review
focuses
on
diverse
highlight
importance
major
circulating
biomarkers
microRNAs
(miRNAs)
progression
severity.
literature
analysis
showed
proteins
function,
such
Glial
fibrillary
acidic
protein,
neurofilament
light
chain,
p-tau
181,
Ubiquitin
C-terminal
hydrolase
L1,
S100
calcium-binding
protein
B,
Neuron-specific
enolase
various
inflammatory
cytokines,
were
significantly
altered
patients.
Furthermore,
among
miRNAs
pivotal
roles
diseases,
miR-146a,
miR-155,
Let-7b,
miR-31,
miR-16
miR-21
shown
significant
dysregulation
Thus
consolidates
important
findings
from
numerous
studies
unravel
underlying
mechanism
neurological
sequelae
possible
association
circulatory
biomarkers,
which
may
serve
predictors
targets
future
research.